Most read article(s)

Open Access
Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
Wolfgang Löscher, Heidrun Potschka, Sanjay M. Sisodiya and Annamaria Vezzani
Eric L. Barker, ASSOCIATE EDITOR

Pharmacological Reviews July 2020, 72 (3) 606-638; DOI: https://doi.org/10.1124/pr.120.019539
Open Access
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Kasper B. Hansen, Lonnie P. Wollmuth, Derek Bowie, Hiro Furukawa, Frank S. Menniti, Alexander I. Sobolevsky, Geoffrey T. Swanson, Sharon A. Swanger, Ingo H. Greger, Terunaga Nakagawa, Chris J. McBain, Vasanthi Jayaraman, Chian-Ming Low, Mark L. Dell’Acqua, Jeffrey S. Diamond, Chad R. Camp, Riley E. Perszyk, Hongjie Yuan and Stephen F. Traynelis
Eric Barker, ASSOCIATE EDITOR

Pharmacological Reviews October 2021, 73 (4) 1469-1658; DOI: https://doi.org/10.1124/pharmrev.120.000131
You have access
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Tobias Atkin, Stefano Comai and Gabriella Gobbi
Eric L. Barker, ASSOCIATE EDITOR

Pharmacological Reviews April 2018, 70 (2) 197-245; DOI: https://doi.org/10.1124/pr.117.014381
Open Access
New Technologies Bloom Together for Bettering Cancer Drug Conjugates
Yiming Jin, Shahab Edalatian Zakeri, Raman Bahal and Andrew J. Wiemer
Eric Barker, ASSOCIATE EDITOR

Pharmacological Reviews July 2022, 74 (3) 680-713; DOI: https://doi.org/10.1124/pharmrev.121.000499
Open Access
Is Oxytocin “Nature’s Medicine”?
C. Sue Carter, William M. Kenkel, Evan L. MacLean, Steven R. Wilson, Allison M. Perkeybile, Jason R. Yee, Craig F. Ferris, Hossein P. Nazarloo, Stephen W. Porges, John M. Davis, Jessica J. Connelly and Marcy A. Kingsbury
Robert Dantzer, ASSOCIATE EDITOR

Pharmacological Reviews October 2020, 72 (4) 829-861; DOI: https://doi.org/10.1124/pr.120.019398
Open Access
The Nitrogen Mustards
Martin S. Highley, Bart Landuyt, Hans Prenen, Peter G. Harper and Ernst A. De Bruijn
Michael Gottesman, ASSOCIATE EDITOR

Pharmacological Reviews July 2022, 74 (3) 552-599; DOI: https://doi.org/10.1124/pharmrev.120.000121
Open Access
Mutations in G Protein–Coupled Receptors: Mechanisms, Pathophysiology and Potential Therapeutic Approaches
Torsten Schöneberg and Ines Liebscher
Paul Insel, ASSOCIATE EDITOR

Pharmacological Reviews January 2021, 73 (1) 89-119; DOI: https://doi.org/10.1124/pharmrev.120.000011
You have access
Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications
Jaclyn N. Highland, Panos Zanos, Lace M. Riggs, Polymnia Georgiou, Sarah M. Clark, Patrick J. Morris, Ruin Moaddel, Craig J. Thomas, Carlos A. Zarate, Edna F. R. Pereira and Todd D. Gould
Robert Dantzer, ASSOCIATE EDITOR

Pharmacological Reviews April 2021, 73 (2) 763-791; DOI: https://doi.org/10.1124/pharmrev.120.000149
Open Access
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
Peter Garred, Andrea J. Tenner and Tom E. Mollnes
Finn Olav Levy, ASSOCIATE EDITOR

Pharmacological Reviews April 2021, 73 (2) 792-827; DOI: https://doi.org/10.1124/pharmrev.120.000072
Open Access
Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease
Hilary Grosso Jasutkar, Stephanie E. Oh and M. Maral Mouradian
Eric Barker, ASSOCIATE EDITOR

Pharmacological Reviews January 2022, 74 (1) 207-237; DOI: https://doi.org/10.1124/pharmrev.120.000133

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals